Sources | Names Used |
---|---|
CTRPv2 | BRD-K16130065 |
PharmacoGx | BRD-K16130065 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PHF24 | CTRPv2 | pan-cancer | AAC | 0.4 | 5e-09 |
mRNA | ADI1 | CTRPv2 | pan-cancer | AAC | 0.39 | 5e-09 |
mRNA | OR52I1 | CTRPv2 | pan-cancer | AAC | 0.39 | 7e-09 |
mRNA | COBL | CTRPv2 | pan-cancer | AAC | 0.46 | 7e-09 |
mRNA | GPR148 | CTRPv2 | pan-cancer | AAC | 0.4 | 8e-09 |
mRNA | ROPN1B | CTRPv2 | pan-cancer | AAC | 0.41 | 8e-09 |
mRNA | PLSCR2 | CTRPv2 | pan-cancer | AAC | 0.4 | 9e-09 |
mRNA | PPP1R1B | CTRPv2 | pan-cancer | AAC | 0.4 | 9e-09 |
mRNA | LL0XNC01-16G2.1 | CTRPv2 | pan-cancer | AAC | 0.39 | 1e-08 |
mRNA | A2M | CTRPv2 | pan-cancer | AAC | 0.39 | 1e-08 |